... >
chemical entity >
molecular entity >
main group molecular entity >
p-block molecular entity >
chalcogen molecular entity >
oxygen molecular entity >
organooxygen compound >
carbonyl compound >
2-[(3r,6ar,8r,10ar)-1-[(2-fluorophenyl)-oxomethyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2h-pyrano[2,3-c][1,5]oxazocin-8-yl]-1-(4-methyl-1-piperazinyl)ethanone
... >
chemical entity >
molecular entity >
main group molecular entity >
p-block molecular entity >
chalcogen molecular entity >
organochalcogen compound >
organooxygen compound >
carbonyl compound >
2-[(3r,6ar,8r,10ar)-1-[(2-fluorophenyl)-oxomethyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2h-pyrano[2,3-c][1,5]oxazocin-8-yl]-1-(4-methyl-1-piperazinyl)ethanone
... >
chemical entity >
molecular entity >
main group molecular entity >
p-block molecular entity >
carbon group molecular entity >
organic molecular entity >
heteroorganic entity >
organochalcogen compound >
organooxygen compound >
carbonyl compound >
2-[(3r,6ar,8r,10ar)-1-[(2-fluorophenyl)-oxomethyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2h-pyrano[2,3-c][1,5]oxazocin-8-yl]-1-(4-methyl-1-piperazinyl)ethanone
... >
chemical entity >
molecular entity >
main group molecular entity >
p-block molecular entity >
carbon group molecular entity >
organic molecular entity >
organic molecule >
organic oxo compound >
carbonyl compound >
2-[(3r,6ar,8r,10ar)-1-[(2-fluorophenyl)-oxomethyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2h-pyrano[2,3-c][1,5]oxazocin-8-yl]-1-(4-methyl-1-piperazinyl)ethanone
... >
chemical entity >
molecular entity >
polyatomic entity >
molecule >
organic molecule >
organic oxo compound >
carbonyl compound >
2-[(3r,6ar,8r,10ar)-1-[(2-fluorophenyl)-oxomethyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2h-pyrano[2,3-c][1,5]oxazocin-8-yl]-1-(4-methyl-1-piperazinyl)ethanone
... >
chemical entity >
molecular entity >
polyatomic entity >
heteroatomic molecular entity >
halide >
organohalogen compound >
2-[(3r,6ar,8r,10ar)-1-[(2-fluorophenyl)-oxomethyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2h-pyrano[2,3-c][1,5]oxazocin-8-yl]-1-(4-methyl-1-piperazinyl)ethanone
... >
chemical entity >
molecular entity >
main group molecular entity >
p-block molecular entity >
halogen molecular entity >
halide >
organohalogen compound >
2-[(3r,6ar,8r,10ar)-1-[(2-fluorophenyl)-oxomethyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2h-pyrano[2,3-c][1,5]oxazocin-8-yl]-1-(4-methyl-1-piperazinyl)ethanone
... >
chemical entity >
molecular entity >
main group molecular entity >
p-block molecular entity >
carbon group molecular entity >
organic molecular entity >
heteroorganic entity >
organohalogen compound >
2-[(3r,6ar,8r,10ar)-1-[(2-fluorophenyl)-oxomethyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2h-pyrano[2,3-c][1,5]oxazocin-8-yl]-1-(4-methyl-1-piperazinyl)ethanone
Preferred term
2-[(3r,6ar,8r,10ar)-1-[(2-fluorophenyl)-oxomethyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2h-pyrano[2,3-c][1,5]oxazocin-8-yl]-1-(4-methyl-1-piperazinyl)ethanone
inchi
-
InChI=1S/C23H32FN3O5/c1-25-8-10-26(11-9-25)22(29)12-17-6-7-20-21(32-17)15-31-14-16(28)13-27(20)23(30)18-4-2-3-5-19(18)24/h2-5,16-17,20-21,28H,6-15H2,1H3/t16-,17-,20-,21+/m1/s1
inchikey
-
JLPSQBARJGYMKN-DGQTTZFYSA-N
smiles
-
CN1CCN(CC1)C(=O)C[C@H]2CC[C@@H]3[C@@H](O2)COC[C@@H](CN3C(=O)C4=CC=CC=C4F)O
-
2 [(3R,6aR,8R,10aR) 1 [(2 fluorophenyl) oxomethyl] 3 hydroxy 3,4,6,6a,8,9,10,10a octahydro 2H pyrano[2,3 c][1,5]oxazocin 8 ylet ylet 1 (4 m) پیپینه
URI
http://www.irandoc.acir/onto/irandoc/CHEBI:100663